Arkray

Qiagen has been awarded

The University of Massachusetts has been awarded

Olink of Uppsala, Sweden, has been awarded US Patent No. RE44,265, "Nucleic acid amplification method," a reissue of US Patent No. 7,790,388 of the same name.
Ulf Landegren and Mats Gullberg are named as inventors.

Ibis Biosciences (Abbott) has been awarded US Patent No. 8,407,010, "Methods for rapid forensic analysis of mitochondrial DNA."
Steven Hofstadler, Thomas Hall, David Ecker, Lawrence Blyn, Mark Eshoo, Vivek Samant, and Neill White are named as inventors.

Arkray has been awarded US Patent No. 8,357,516, "Primer set for amplification of UGT1A1 gene, reagent for amplification of UGT1A1 gene containing the same, and the uses thereof."
Mitsuharu Hirai and Satoshi Majima are named as inventors.

Arkray of Kyoto, Japan, has been awarded US Patent No. 8,306,754, "Nucleic acid amplification determining method and nucleic acid amplification determining device."
Kosuke Kubo is named as the inventor.

Canon US Life Sciences has been awarded US Patent No. 8,232,094, "Real-time PCR in micro-channels."
Kenton Hasson, Gregory Dale, and Hiroshi Inoue are named as inventors on the patent.

The University of North Carolina at Chapel Hill has been awarded US Patent No. 8,148,511, "Methods and compositions for the detection and quantification of E. coli and Enterococcus."

Roche Molecular Systems has been awarded US Patent No. 8,024,132, "Method for the efficiency-corrected real-time quantification of nucleic acids."
Gregor Sagner, Karim Tabiti, Martin Gutekunst, and Richie Soong are named as inventors on the patent.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.